Risk Factors for Recent HIV Infections among Adults in 14 Countries in Africa Identified by Population-Based HIV Impact Assessment Surveys, 2015-2019.
Cameroon
Côte d’Ivoire
Eswatini
Ethiopia
HIV
HIV/AIDS and other retroviruses
Kenya
Lesotho
Malawi
Namibia
Nigeria
PHIA
Population-Based HIV Impact Assessment
Rwanda
Tanzania
Uganda
Zambia
Zimbabwe
cross-sectional studies
sexually transmitted diseases
sexually transmitted infections
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
medline:
26
10
2023
pubmed:
25
10
2023
entrez:
25
10
2023
Statut:
ppublish
Résumé
Identifying persons who have newly acquired HIV infections is critical for characterizing the HIV epidemic direction. We analyzed pooled data from nationally representative Population-Based HIV Impact Assessment surveys conducted across 14 countries in Africa for recent infection risk factors. We included adults 15-49 years of age who had sex during the previous year and used a recent infection testing algorithm to distinguish recent from long-term infections. We collected risk factor information via participant interviews and assessed correlates of recent infection using multinomial logistic regression, incorporating each survey's complex sampling design. Compared with HIV-negative persons, persons with higher odds of recent HIV infection were women, were divorced/separated/widowed, had multiple recent sex partners, had a recent HIV-positive sex partner or one with unknown status, and lived in communities with higher HIV viremia prevalence. Prevention programs focusing on persons at higher risk for HIV and their sexual partners will contribute to reducing HIV incidence.
Identifiants
pubmed: 37877591
doi: 10.3201/eid2911.230703
pmc: PMC10617335
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2325-2334Subventions
Organisme : CGH CDC HHS
ID : U2G GH001226
Pays : United States
Organisme : PEPFAR
Pays : United States
Références
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):453-9
pubmed: 21297483
N Engl J Med. 2018 May 17;378(20):1859-1861
pubmed: 29768142
Transbound Emerg Dis. 2020 Nov;67(6):2372-2388
pubmed: 32396689
Lancet HIV. 2017 Oct;4(10):e457-e464
pubmed: 28801191
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S89-S96
pubmed: 33765683
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S17-S27
pubmed: 34166309
MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):329-334
pubmed: 35239633
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S6-S16
pubmed: 34166308
Curr HIV/AIDS Rep. 2020 Jun;17(3):249-258
pubmed: 32297219
J Int AIDS Soc. 2021 Oct;24(10):e25818
pubmed: 34672104
J Acquir Immune Defic Syndr. 2023 Mar 1;92(3):189-196
pubmed: 36730779
AIDS Res Ther. 2013 Dec 13;10(1):30
pubmed: 24330537
J Int AIDS Soc. 2022 Jan;25(1):e25861
pubmed: 35001515
BMC Infect Dis. 2020 Mar 6;20(1):198
pubmed: 32138696
PLoS One. 2012;7(3):e33328
pubmed: 22479384
J Infect Dis. 2023 Apr 01;:
pubmed: 37002831
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S73-S80
pubmed: 34166315
JAMA. 2008 Aug 6;300(5):540-9
pubmed: 18677026
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003362
pubmed: 19370585
Lancet HIV. 2019 Dec;6(12):e831-e859
pubmed: 31439534
HIV AIDS (Auckl). 2019 May 16;11:105-117
pubmed: 31191036
PLoS One. 2016 May 19;11(5):e0155498
pubmed: 27195800
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
Nat Commun. 2019 Dec 2;10(1):5482
pubmed: 31792217
Lancet HIV. 2021 Jul;8(7):e429-e439
pubmed: 34197773
PLoS Med. 2018 Oct 25;15(10):e1002678
pubmed: 30359372
JAMA. 2016 Jul 12;316(2):171-81
pubmed: 27404185
Lancet HIV. 2018 Apr;5(4):e181-e189
pubmed: 29490875
AIDS. 2019 Jul 15;33(9):1527-1529
pubmed: 31021850